Objective
Vaccinations are a highly efficient and effective means for protecting humans and animals against severe diseases. For reaching an initial protective immune response, the vaccine must repeatedly be administered, mainly by injection. Omitting the repeated vaccine injections either due to the unavailability of medical personnel (mainly in developing countries) or due to negligence results in insufficient protection and susceptibility to disease.
One solution for overcoming this lack in protection would be a vaccination strategy avoiding the need for additional appointments with medical personnel. This could be realized by the use of a vaccine depot that is injected together with the first vaccine dose. At a preset time point the patient would simply swallow a pill containing a trigger substance that would subsequently induce the release of the vaccine from the depot and induce the subsequent protection of the patient.
In this project we will perform the proof of concept for the functionality of such a depot in animal models using vaccines against widespread infectious diseases like hepatitis B or human papilloma virus.
With this study we aim at demonstrating the proof of concept that our newly developed materials can be applied to increase the patient compliance of vaccinations and thereby to increase the vaccination success rate. As our approach is likely generically applicable to different vaccines, we anticipate a highly attractive economical potential in the human medical and the veterinary fields. The scientific data obtained in this project together with a comprehensive market research and the development of a business strategy will shape a highly attractive commercial proposition for the successful valorization of our current ERC-funded research.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
- natural sciences biological sciences microbiology virology
- medical and health sciences health sciences infectious diseases
- medical and health sciences basic medicine immunology
- medical and health sciences basic medicine pharmacology and pharmacy pharmaceutical drugs vaccines
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
ERC-2012-PoC
See other projects for this call
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Host institution
79098 Freiburg
Germany
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.